Skip to content

"Ayurvedic Management Of Rheumatoid Arthritis .

"Randomised Controlled Trial Of Panchasam Churna with Vaitaran Basti In The Management Of Amavata With Special Referance To Rheumatoid Arthritis â??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019523
Enrollment
80
Registered
2019-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Panchasama Churna With Vaitaran Basti: Langhana and Pachana for 3-5 days oral administration of Panchasam Churna 5 gm for two times per day After meal with lukewarm water. One Vaitar

Sponsors

Government Ayurved College and Hospital Nagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having signs and symptoms of Amavata mentioned in Ayurvedic texts. 2) All patients fulfilling a score of 6/10 is needed for classification of a patient as having definite Rheumatoid Arthritis which is American criteria of Rheumatoid Arthritis (2010). 3) Patients of either sex aged between 25-70 years. 4) Patient willing and able to participate in the study. 5) Patients who have not participated in any research projects since last 6 months. 6) Patients of rheumatoid arthritis having controlled hypertension and Diabetes Mellitus may also be included. 7) Patients of Aamvata having Sama Avastha will only be included in study.

Exclusion criteria

Exclusion criteria: 1) Patients who are not willing for trial. 2) Patients having gross disability in performing daily normal routine i.e. bed ridden patients or confined to a wheel chair or have to take help to perform daily routine activity. 3) Patients having gouty arthritis, syphilitic arthritis, psoriatic arthritis, rheumatic arthritis, tubercular arthritis, gonococcal arthritis etc. 4) Patients with poorly controlled Hypertension. 5) Patients with poorly controlled Diabetes Mellitus. 6) Patients with the evidence of malignancy. 7) Patients on prolonged medication ( >6weeks) with corticosteroids, or any other drugs that may have an influence on the outcome of the study. 8) Patients who are currently participating in any other clinical trials (since last 6 months). 9) Pregnant or lactating ladies. 10) Patient with chronicity more than >6 years. 11) Patient with contracture and having deformity in the joints. 12) Patients who are contraindicated for Basti Karma.

Design outcomes

Primary

MeasureTime frame
1. Panchasam Churna with Vaitarana Basti will be more effective than Devdarvyadi Churna with Vaitarana Basti in the management of Amavat.Timepoint: 18 months

Secondary

MeasureTime frame
1. To compare the effect of oral administration of Panchasam Churna with Vaitarana Basti with that of Devdarvyadi Churna with Vaitarana Basti on clinical features of Amavata and disability index score of Rheumatoid Arthritis Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Jayant Gulhane

Government Ayurved College and hospital Nagpur

jayant.gulhane.62.6@gmail.com9822922399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026